Literature DB >> 16980437

Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function.

Sarah L Gray1, Edoardo Dalla Nora, Emma C Backlund, Monia Manieri, Sam Virtue, Robert C Noland, Stephen O'Rahilly, Ronald N Cortright, Saverio Cinti, Barbara Cannon, Antonio Vidal-Puig.   

Abstract

Mice with a dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutation (P465L) unexpectedly had normal amounts of adipose tissue. Here, we investigate the adipose tissue of the PPARgamma P465L mouse in detail. Microscopic analysis of interscapular adipose tissue of P465L PPARgamma mice revealed brown adipocytes with larger unilocular lipid droplets, indicative of reduced thermogenic capacity. Under conditions of cold exposure, the brown adipose tissue of the PPARgamma P465L mice was less active, a fact reflected in decreased uncoupling protein 1 levels. Analysis of the white adipocytes confirmed their normal cytoarchitecture and development, yet classical white adipose depots of the P465L PPARgamma mice had a striking reduction in brown adipocyte recruitment, a finding supported by reduced expression of UCP1 in the perigonadal adipose depot. Taken together, these data suggest that whole animal impairment of PPARgamma alters the cellular composition of the adipose organ to a more "white" adipose phenotype. Physiologically, this impairment in brown adipocyte recruitment is associated with decreased nonshivering thermogenic capacity after cold acclimation as revealed by norepinephrine responsiveness. Our results indicate that maintenance of oxidative brown-like adipose tissue is more dependent on PPARgamma function for development than white adipose tissue, an observation that may be relevant when considering PPARgamma-dependent strategies for the treatment of obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980437     DOI: 10.1210/en.2006-0684

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein.

Authors:  Haruya Ohno; Kosaku Shinoda; Bruce M Spiegelman; Shingo Kajimura
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

2.  PPARgamma differentially regulates energy substrate handling in brown vs. white adipose: focus on "The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake".

Authors:  Justin L Grobe; Marcia Venegas-Pont; Curt D Sigmund; Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-04       Impact factor: 3.619

Review 3.  Adaptive thermogenesis in adipocytes: is beige the new brown?

Authors:  Jun Wu; Paul Cohen; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

4.  1,25-Dihydroxyvitamin D3/vitamin D receptor suppresses brown adipocyte differentiation and mitochondrial respiration.

Authors:  Carolyn J Ricciardi; Jiyoung Bae; Debora Esposito; Slavko Komarnytsky; Pan Hu; Jiangang Chen; Ling Zhao
Journal:  Eur J Nutr       Date:  2014-10-09       Impact factor: 5.614

Review 5.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

Review 6.  Transcriptional control and hormonal response of thermogenic fat.

Authors:  Margo P Emont; Hui Yu; Jun Wu
Journal:  J Endocrinol       Date:  2015-03-24       Impact factor: 4.286

Review 7.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

8.  Targeting fat to prevent diabetes.

Authors:  Jaswinder K Sethi; Antonio J Vidal-Puig
Journal:  Cell Metab       Date:  2007-05       Impact factor: 27.287

9.  PPARγ activation attenuates cold-induced upregulation of thyroid status and brown adipose tissue PGC-1α and D2.

Authors:  William T Festuccia; Pierre-Gilles Blanchard; Thiago B Oliveira; Juliana Magdalon; Vivian A Paschoal; Denis Richard; Yves Deshaies
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

10.  Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC.

Authors:  Oscar Rubio-Cabezas; Vishwajeet Puri; Incoronata Murano; Vladimir Saudek; Robert K Semple; Satya Dash; Caroline S S Hyden; William Bottomley; Corinne Vigouroux; Jocelyne Magré; Philippa Raymond-Barker; Peter R Murgatroyd; Anil Chawla; Jeremy N Skepper; V Krishna Chatterjee; Sara Suliman; Ann-Marie Patch; Anil K Agarwal; Abhimanyu Garg; Inês Barroso; Saverio Cinti; Michael P Czech; Jesús Argente; Stephen O'Rahilly; David B Savage
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.